VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 86 filers reported holding VERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,686,027 | +156.0% | 1,727,646 | +199.7% | 0.00% | – |
| Q2 2023 | $9,253,611 | +292.1% | 576,549 | +89.6% | 0.00% | – |
| Q1 2023 | $2,360,181 | -76.2% | 304,147 | -40.8% | 0.00% | – |
| Q4 2022 | $9,934,136 | +86.6% | 513,392 | +105.5% | 0.00% | – |
| Q3 2022 | $5,323,000 | +76.0% | 249,783 | +12.4% | 0.00% | – |
| Q2 2022 | $3,025,000 | -23.7% | 222,255 | +31.7% | 0.00% | – |
| Q1 2022 | $3,964,000 | +20.3% | 168,757 | +36.9% | 0.00% | – |
| Q4 2021 | $3,294,000 | +152.2% | 123,273 | +63.8% | 0.00% | – |
| Q3 2021 | $1,306,000 | – | 75,255 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 5,450,000 | $74,719,500 | 8.73% |
| Kynam Capital Management, LP | 2,956,053 | $40,527,487 | 6.63% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 758,355 | $10,381,880 | 3.50% |
| Sofinnova Investments, Inc. | 3,467,156 | $47,534,709 | 3.00% |
| Altium Capital Management LP | 333,681 | $4,574,767 | 2.39% |
| Eversept Partners, LP | 1,478,489 | $20,270,084 | 1.72% |
| SECTORAL ASSET MANAGEMENT INC | 357,139 | $4,896,376 | 0.95% |
| Carlyle Group Inc. | 1,438,155 | $19,688,342 | 0.85% |
| Orbimed Advisors | 1,518,115 | $20,813,357 | 0.44% |
| Woodline Partners LP | 2,562,600 | $35,133,246 | 0.41% |